A review of natural and synthetic antioxidants important for health and longevity

Current Medicinal Chemistry

Volumn 17, Issue 28, 2010, Pages 3262-3288

  Wojcik, M ^a   Burzynska Pedziwiatr, I ^a   Wozniak, L A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Carotenoids; Polyphenols; Reactive oxygen species; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; BILIRUBIN; CAROTENOID; CATALASE; CATECHIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LYCOPENE; POLYPHENOL; PROCYANIDIN; PROCYANIDIN B2; RESVERATROL; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URATE; XANTHOPHYLL; ZEAXANTHIN; ZINC; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; REACTIVE OXYGEN METABOLITE;

CARDIOVASCULAR DISEASE; CATARACT; DEGENERATIVE DISEASE; DNA DAMAGE; HUMAN; LONGEVITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; REVIEW; RHEUMATOID ARTHRITIS; CHEMISTRY; CLINICAL TRIAL (TOPIC); HEALTH; METABOLISM;

ANTIOXIDANTS; ASCORBIC ACID; CAROTENOIDS; CLINICAL TRIALS AS TOPIC; FLAVONOIDS; HEALTH; HUMANS; LONGEVITY; PHENOLS; REACTIVE OXYGEN SPECIES; VITAMIN E;

EID: 77957753126     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986710792231950     Document Type: Review

References (276)

1. Sohal, R. S.; Weindruch, R. Oxidative stress, caloric restriction, and aging. Science, 1996, 273, 59-63. (Pubitemid 26255420)
2. Ghafourifar, P.; Sen, C. K. Mitochondrial nitric oxide synthase. Front Biosci., 2007, 12, 1072-1078. (Pubitemid 46846879)
3. Inoue, M.; Sato, E. F.; Nishikawa, M.; Park, A. M.; Kira, Y.; Imada, I.; Utsumi, K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr. Med. Chem., 2003, 10, 2495-2505. (Pubitemid 37460972)
4. Capdevila, J.; Parkhill, L.; Chacos, N.; Okita, R.; Masters, B. S.; Estabrook, R. W. The oxidative metabolism of arachidonic acid by purified cytochromes P-450. Biochem. Biophys. Res. Commun., 1981, 101, 1357-1363. (Pubitemid 12200642)
5. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C. J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell Biochem., 2004, 266, 37-56. (Pubitemid 39562306)
6. Nohl, H.; Gille, L.; Staniek, K. Intracellular generation of reactive oxygen species by mitochondria. Biochem. Pharmacol., 2005, 69, 719-723. (Pubitemid 40248614)
7. Fridovich, I. Biological effects of the superoxide radical. Arch. Biochem. Biophys., 1986, 247, 1-11. (Pubitemid 16076916)
8. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M. T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007, 39, 44-84. (Pubitemid 44566469)
9. Chance, B.; Sies, H.; Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev., 1979, 59, 527-605. (Pubitemid 9236599)
10. Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem., 1995, 64, 97-112.
11. Desideri, A.; Falconi, M. Prokaryotic Cu, Zn superoxide dismutases. Biochem. Soc. Trans., 2003, 31, 1322-1325.
12. Bowler, C.; Van Montagu, M.; Inze, D. Superoxide dismutase and stress tolerance. Annu. Rev. Plant Physiol. Plant Mol. Biol., 1992, 43, 83-116.
13. Michiels, C.; Raes, M.; Toussaint, O.; Remacle, J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med., 1994, 17, 235-248.
14. Pastor, N.; Weinstein, H.; Jamison, E.; Brenowitz, M. A detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding. J. Mol. Biol., 2000, 304, 55-68.
15. Lindahl, T. Instability and decay of the primary structure of DNA. Nature, 1993, 362, 709-715. (Pubitemid 23125973)
16. Wagner, B. A.; Buettner, G. R.; Burns, C. P. Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry, 1994, 33, 4449-4453. (Pubitemid 24145090)
17. Ridnour, L. A.; Thomas, D. D.; Mancardi, D.; Espey, M. G.; Miranda, K. M.; Paolocci, N.; Feelisch, M.; Fukuto, J.; Wink, D. A. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol. Chem., 2004, 385, 1-10. (Pubitemid 38240288)
18. Thannickal, V. J.; Fanburg, B. L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol., 2000, 279, L1005-1028. (Pubitemid 32009487)
19. Storz, P. Reactive oxygen species-mediated mitochondria-tonucleus signaling: a key to aging and radical-caused diseases. Sci. STKE, 2006, (332): re3.
20. Storz, P. Reactive oxygen species in tumor progression. Front Biosci., 2005, 10, 1881-1896. (Pubitemid 40529044)
21. Seifried, H. E.; Anderson, D. E.; Fisher, E. I.; Milner, J. A. A review of the interaction among dietary antioxidants and reactive oxygen species. J. Nutr. Biochem., 2007, 18, 567-579. (Pubitemid 47214661)
22. Levine, M.; Rumsey, S. C.; Daruwala, R.; Park, J. B.; Wang, Y. Criteria and recommendations for vitamin C intake. JAMA, 1999, 281, 1415-1423. (Pubitemid 29190220)
23. Jacob, R. A.; Sotoudeh, G. Vitamin C function and status in chronic disease. Nutr. Clin. Care, 2002, 5, 66-74.
24. Hamilton, I. M.; Gilmore, W. S.; Benzie, I. F.; Mulholland, C. W.; Strain, J. J. Interactions between vitamins C and E in human subjects. B r. J. Nutr., 2000, 84, 261-267.
25. Cameron, E.; Campbell, A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem. Biol. Interact., 1974, 9, 285-315.
26. Murata, A.; Morishige, P.; Yamaguchi, H. Prolongation of survival times of teminal cancer patients by administration of arge doses of ascorbate. Int. J. Vitam. Nutr. Res., 1982, 23, 103-113.
27. Creagan, E. T.; Moertel, C. G.; O'Fallon, J. R.; Schutt, A. J.; O'Connell, M. J.; Rubin, J.; Frytak, S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med., 1979, 301, 687-690. (Pubitemid 10240445)
28. Moertel, C. G.; Fleming, T. R.; Creagan, E. T.; Rubin, J.; O'Connell, M. J.; Ames, M. M. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med., 1985, 312, 137-141. (Pubitemid 15192859)
29. Padayatty, S. J.; Sun, H.; Wang, Y.; Riordan, H. D.; Hewitt, S. M.; Katz, A.; Wesley, R. A.; Levine, M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med., 2004, 140, 533-537.
30. Chen, Q.; Espey, M. G.; Sun, A. Y.; Lee, J. H.; Krishna, M. C.; Shacter, E.; Choyke, P. L.; Pooput, C.; Kirk, K. L.; Buettner, G. R.; Levine, M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl. Acad. Sci. USA, 2007, 104, 8749-8754. (Pubitemid 47175383)
31. Chen, Q.; Espey, M. G.; Sun, A. Y.; Pooput, C.; Kirk, K. L.; Krishna, M. C.; Khosh, D. B.; Drisko, J.; Levine, M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA, 2008, 105, 11105-11109.
32. Chen, Q.; Espey, M. G.; Krishna, M. C.; Mitchell, J. B.; Corpe, C. P.; Buettner, G. R.; Shacter, E.; Levine, M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA, 2005, 102, 13604-13609. (Pubitemid 41420895)
33. Padayatty, S. J.; Riordan, H. D.; Hewitt, S. M.; Katz, A.; Hoffer, L. J.; Levine, M. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ, 2006, 174, 937-942.
34. Riordan, H. D.; Casciari, J. J.; Gonzalez, M. J.; Riordan, N. H.; Miranda-Massari, J. R.; Taylor, P.; Jackson, J. A. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. PR Health Sci. J., 2005, 24, 269-276.
35. Catani, M. V.; Costanzo, A.; Savini, I.; Levrero, M.; de Laurenzi, V.; Wang, J. Y. J.; Melino, G.; Avigliano, L. Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage. Biochem. J., 2002, 364, 441-447. (Pubitemid 34620804)
36. Reddy, V. G.; Khanna, V.; Singh, N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing p53. Biochem. Biophys. Res. Commun., 2001, 282, 409-415. (Pubitemid 32917884)
37. Hahm, E.; Jin, D. H.; Kang, J. S.; Kim, Y. I.; Hong, S. W.; Lee, S. K.; Kim, H. N.; Jung da, J.; Kim, J. E.; Shin, D. H.; Hwang, Y. I.; Kim, Y. S.; Hur, D. Y.; Yang, Y.; Cho, D.; Lee, M. S.; Lee, W. J. The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma. J. Cell Biochem., 2007, 102, 1002-1010. (Pubitemid 350036939)
38. Karin, M.; Lin, A. NF-kappaB at the crossroads of life and death. Nat. Immunol, 2002, 3, 221-227.
39. Valko, M.; Rhodes, C. J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 160, 1-40. (Pubitemid 43227479)
40. Bowie, A. G.; O'Neill, L. A. Vitamin C inhibits NF-kB activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol, 2000, 165, 7180-7188. (Pubitemid 32001195)
41. Carcamo, J. M.; Pedraza A.; Borquez-Ojeda, O.; Golde, D. W. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry, 2002, 41, 12995-13002. (Pubitemid 35215783)
42. Lee, W. J. The prospects of vitamin C in cancer therapy. Immune Netw., 2009, 9, 147-152.
43. Kim, K. N.; Pie, J. E.; Park, J. H.; Park, Y. H.; Kim, H. W.; Kim, M. K. Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation. J. Nutr. Biochem., 2006, 17, 454-462.
44. Bjelakovic, G.; Nikolova, D.; Gluud, L. L.; Simonetti, R. G.; Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev., 2008, 2, CD007176.
45. Parthasarathy, S.; Steinberg, D.; Witztum, J. L. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med., 1992, 43, 219-225.
46. Berliner, J. A.; Heinecke, J. W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med., 1996, 20, 707-727. (Pubitemid 26105783)
47. Dhalla, N. S.; Temsah, R. M.; Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. Hypertens., 2000, 18, 655-673. (Pubitemid 30406736)
48. Steinberg, D.; Lewis, A.; Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation, 1997, 95, 1062-1071.
49. Ginter, E. Marginal vitamin C deficiency, lipid metabolism and atherogenesis. Adv. Lipid Res., 1978, 16, 167-215.
50. Fernandez, M. L.; Vega, S.; Ayala, M. T.; Shen, H.; Conde, K.; Vergara-Jimenez, M.; Robbins, A. Vitamin C level and dietary fat saturation alter hepatic cholesterol homeostasis and plasma LDL metabolism in guinea pigs. J. Nutr. Biochem., 1997, 8, 414-424. (Pubitemid 27344882)
51. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch. Intern. Med., 2007, 167, 1610-1618. (Pubitemid 47280341)
52. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briançon S. The SU. VI. MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med., 2004, 164, 2335-2342. (Pubitemid 39532244)
53. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002, 360, 23-33.
54. Sesso, H. D.; Buring, J. E.; Christen, W. G.; Kurth, T.; Belanger, C.; MacFadyen, J.; Bubes, V.; Manson, J. E.; Glynn, R. J.; Gaziano, J. M. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA, 2008, 300, 2123-2133.
55. Salonen, J. T.; Nyyssönen, K.; Salonen, R.; Lakka, H. M.; Kaikkonen, J.; Porkkala-Sarataho, E.; Voutilainen, S.; Lakka, T. A.; Rissanen, T.; Leskinen, L.; Tuomainen, T. P.; Valkonen, VP.; Ristonmaa, U.; Poulsen, H. E. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Intern. Med., 2000, 248, 377-386.
56. Sundram, K.; Sambanthamurthi, R.; Tan, Y. A. Palm fruit chemistry and nutrition. Asia Pac. J. Clin. Nutr. 2003, 12, 355-362. (Pubitemid 38880724)
57. Traber, M. G. Vitamin E regulatory mechanisms. Annu. Rev. Nutr, 2007, 27, 347-362. (Pubitemid 351373361)
58. Mustacich, D. J.; Leonard, S. W.; Patel, N. K.; Traber, M. G. Alphatocopherol beta-oxidation localized to rat liver mitochondria. Free Radic. Biol. Med., 2010, 48, 73-81.
59. Brigelius-Flohe, R.; Traber, M. G. Vitamin E: function and metabolism. FASEB J., 1999, 13, 1145-1155. (Pubitemid 29300361)
60. Bruno, R. S.; Leonard, S. W.; Atkinson, J.; Montine, T. J.; Ramakrishnan, R.; Bray, T. M.; Traber, M. G. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic. Biol. Med., 2006, 40, 689-97. (Pubitemid 43170821)
61. Siekmeier, R.; Steffen, C.; Marz, W. Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations. J. Cardiovasc. Pharmacol. Ther, 2007, 12, 265-282. (Pubitemid 350264698)
62. Stephens, N. G.; Parsons, A.; Schofield, P. M.; Kelly, F.; Cheeseman, K.; Mitchinson, M. J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet, 1996, 347, 781-786. (Pubitemid 26091640)
63. Stampfer, M. J.; Hennekens, C. H.; Manson, J. E.; Colditz, G. A.; Rosner, B.; Willett, W. C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med., 1993, 328, 1444-1449. (Pubitemid 23143846)
64. Rimm, E. B.; Stampfer, M. J.; Ascherio, A.; Giovannucci, E.; Colditz, G. A.; Willett, W. C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med., 1993, 328, 1450-1456. (Pubitemid 23143847)
65. Boaz, M.; Smetana, S.; Weinstein, T.; Matas, Z.; Gafter, U.; Iaina, A.; Knecht, A.; Weissgarten, Y.; Brunner, D.; Fainaru, M.; Green, M. S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebocontrolled trial. Lancet, 2000, 356, 1213-1218.
66. de Gaetano, G. Collaborative group of the primary prevention project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative group of the primary prevention project. Lancet, 2001, 357, 89-95.
67. Hodis, H. N.; Mack, W. J.; LaBree, L.; Mahrer, P. R.; Sevanian, A.; Liu, C. R.; Liu, C. H.; Hwang, J.; Selzer, R. H.; Azen, S. P. VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation, 2002, 106, 1453-1459.
68. Weinberg, R. B.; VanderWerken, B. S.; Anderson, R. A.; Stegner, J. E.; Thomas, M. J. Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler. Thromb. Vasc. Biol, 2001, 21, 1029-1033. (Pubitemid 34168664)
69. Stocker, R.; Keaney, J. F. Role of oxidative modifications in atherosclerosis. Physiol. Rev., 2004, 84, 1381-1478. (Pubitemid 39302636)
70. Sen, C. K.; Khanna, S.; Roy, S. Tocotrienols: vitamin E beyond tocopherols. Life Sci., 2006, 78, 2088-2098.
71. Neuzil, J.; Weber, T.; Schroder, A.; Lu, M.; Ostermann, G.; Gellert, N.; Mayne, G.; Olejnicka, B.; Negre-Salvayre, A.; Sticha, M.; Coffey, R.; Weber, C. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J., 2001, 15, 403-415. (Pubitemid 32141432)
72. Zhang, M.; Altuwaijri, S.; Yeh, S. RRR-a-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene, 2004, 23, 3080-3088. (Pubitemid 38648198)
73. Quin, J.; Engle, D.; Litwiller, A.; Penalta, E.; Grasch, A.; Boley, T.; Hazelrigg, S. Vitamin E succinate decreases lung cancer tumor growth in mice. J. Surg. Res., 2005, 127, 139-143. (Pubitemid 41080625)
74. Stapelberg, M.; Gellert, N.; Swettenham, E.; Tomasetti, M.; Witting, P. K.; Procopio, A.; Neuzil, J. α-Tocopheryl succinate inhibits malignant mesothelioma by disrupting the FGF autocrine loop: The role of oxidative stress. J. Biol. Chem., 2005, 280, 25369-25376. (Pubitemid 40962239)
75. Dong, L. F.; Swettenham, E.; Eliasson, J.; Wang, X-F.; Gold, M.; Medunic, V.; Stantic, M.; Low, P.; Prochazka, L.; Witting, P. K.; Turanek, J.; Akporiaye, E. T.; Ralph, S. J.; Neuzil, J. Vitamin E analogues inhibit angiogenesis by selective apoptosis induction in proliferating endothelial cells: The role of oxidative stress. Cancer Res., 2007, 67, 11906-11913.
76. Yamamoto, S.; Tamai, H.; Ishisaka, R.; Kanno, T.; Arita, K.; Kobuchi, H.; Utsumi, K. Mechanism of alpha-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells. Free Radic. Res., 2000, 33, 407-418.
77. Yu, W.; Sanders, B. G.; Kline, K. RRR-alpha-tocopheryl succinateinduced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res., 2003, 63, 2483-2491. (Pubitemid 36605187)
78. The α-Tocopherol β Carotene Cancer Prevention Study Group. The effect of witamin E and β carotene on the incidence of lung Cancer and other cancers in male smokers. N. Engl. J. Med., 1994, 330, 1029-1035.
79. Weinstein, S. J.; Wright, M. E.; Lawson, K. A.; Snyder, K.; Männistö, S.; Taylor, PR.; Virtamo, J.; Albanes, D. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 1253-1259. (Pubitemid 46984967)
80. Kirsh, V. A.; Hayes, R. B.; Mayne, S. T.; Chatterjee, N.; Subar, A. F.; Dixon, L. B.; Albanes, D.; Andriole, G. L.; Urban, D. A.; Peters, U. PLCO Trial. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J. Natl. Cancer Inst., 2006, 98, 245-254. (Pubitemid 43264708)
81. Heinonen, O. P.; Albanes, D.; Virtamo, J.; Taylor, PR.; Huttunen, J. K.; Hartman, A. M.; Haapakoski, J.; Malila, N.; Rautalahti, M.; Ripatti, S.; Mäenpää, H.; Teerenhovi, L.; Koss, L.; Virolainen, M.; Edwards, B. K. Prostate cancer and supplementation with alphatocopherol and beta-carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Inst., 1998, 90, 440-446. (Pubitemid 28160635)
82. Eichholzer, M.; Stähelin, H. B.; Lüdin, E.; Bernasconi, F. Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective basel study. Prostate, 1999, 38, 189-198. (Pubitemid 29054935)
83. Chan, J. M.; Stampfer, M. J.; Ma, J.; Rimm, E. B.; Willett, W. C.; Giovannucci, E. L. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol. Biomarkers Prev, 1999, 8, 893-899. (Pubitemid 29508725)
84. Rodriguez, C.; Jacobs, E. J.; Mondul, A. M.; Calle, E. E.; McCullough, M. L.; Thun, M. J. Vitamin E supplements and risk of prostate cancer in U. S. men. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 378-382. (Pubitemid 38737462)
85. Lippman, S. M.; Klein, E. A.; Goodman, P. J.; Lucia, M. S.; Thompson, I. M.; Ford, L. G.; Parnes, H. L.; Minasian, L. M.; Gaziano, J. M.; Hartline, J. A.; Parsons, J. K.; Bearden, J. D 3rd.; Crawford, E. D.; Goodman, G. E.; Claudio, J.; Winquist, E.; Cook, E. D.; Karp, D. D.; Walther, P.; Lieber, M. M.; Kristal, A. R.; Darke, A. K.; Arnold, K. B.; Ganz, PA.; Santella, R. M.; Albanes, D.; Taylor, P. R.; Probstfield, J. L.; Jagpal, T. J.; Crowley, J. J.; Meyskens, F. L Jr.; Baker, L. H.; Coltman, C. A Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 2009, 301, 39-51.
86. Lin, J.; Cook, N. R.; Albert, C.; Zaharris, E.; Gaziano, J. M.; Van Denburgh, M.; Buring, J. E.; Manson, J. E. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J. Natl. Cancer Inst., 2009, 101, 14-23.
87. Bostick, R. M.; Potter, J. D.; McKenzie, D. R.; Sellers, T. A.; Kushi, L. H.; Steinmetz, K. A.; Folsom, A. R. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res., 1993, 53, 4230-4237. (Pubitemid 24146771)
88. Gogos, C. A.; Ginopoulos, P.; Salsa, B.; Apostolidou, E.; Zoumbos, N. C.; Kalfarentzos, F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer, 1998, 82, 395-402. (Pubitemid 28060258)
89. Sen, Ch. K.; Khanna, S.; Roy, S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol. Aspects Med., 2007, 28, 692-728. (Pubitemid 47625534)
90. Voutilainen, S.; Nurmi, T.; Mursu, J.; Rissanen, T. H. Carotenoids and cardiovascular health. Am. J. Clin. Nutr, 2006, 83, 1265-1271. (Pubitemid 44713054)
91. Clevidence, B. A.; Bieri, J. G. Association of carotenoids with human plasma lipoproteins. Methods Enzymol, 1993, 214, 33-46.
92. Krinsky, N. I.; Johnson, E. J. Carotenoids actions and their relation to heath and disease. Mol. Aspects Med., 2005, 26, 459-516. (Pubitemid 41741836)
93. Yeum, K.-J.; Russell, R. M.; Krinsky, N. I.; Aldini, G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch. Biochem. Biophys., 2004, 430, 97-103. (Pubitemid 39119784)
94. Schwartz, J. L.; Singh, R. P.; Teicher, B.; Wright, J. E.; Trites, D. H.; Shklar, G. Induction of a 70KD protein associated with the selective cytotoxicity of beta-carotene in human epidermal carcinoma. Biochem. Biophys. Res. Commun., 1990, 169, 941-946. (Pubitemid 20220710)
95. Hazuka, M. B.; Edwards-Prasad, J.; Newman, F.; Kinzie, J. J.; Prasad, K. N. β-Carotene induces morphological differentiation and decreases adenylate cyclase activity in melanoma cells in culture. J. Am. Coll. Nutr. 1990, 9, 143-149.
96. Stivala, L. A.; Savio, M.; Quarta, S.; Scotti, C.; Cazzalini, O.; Rossi, L.; Scovassi, I. A.; Pizzala, R.; Melli, R.; Bianchi, L.; Vannini, V.; Prosperi, E. The antiproliferative effect of beta-carotene requires p21waf1/cip1 in normal human fibroblasts. Eur. J. Biochem., 2000, 267, 2290-2296. (Pubitemid 30220075)
97. Muller, K.; Carpenter, K. L. H.; Challis, I. R.; Skepper, J. N.; Arends, M. J. Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic. Res., 2002, 36, 791-802. (Pubitemid 34746305)
98. Palozza, P.; Serini, S.; Maggiano, N.; Angelini, M.; Boninsegna, A.; Di Nicuolo, F.; Ranelletti, F. O.; Calviello, G. Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by β-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis, 2002, 23, 11-18. (Pubitemid 34213546)
99. Palozza, P.; Serini, S.; Di Nicuolo, F.; Calviello, G. Mitogenic and apoptotic signaling by carotenoids: involvement of a redox mechanism. IUBMB Life, 2001, 52, 77-81. (Pubitemid 33769674)
100. Palozza, P.; Serini, S.; Torsello, A.; Boninsegna, A.; Covacci, V.; Maggiano, N.; Ranelletti, F. O.; Wolf, F. I.; Calviello, G. Regulation of cell cycle progression and apoptosis by β-carotene in undifferentiated and differentiated HL-60 leukemia cells: possible involvement of a redox mechanism. Int. J. Cancer, 2002, 97, 593-600. (Pubitemid 34087796)
101. Omenn, G. S.; Goodman, G. E.; Thomquist, M. D.; Balmes, J.; Cullen, M. R.; Glass, A.; Keogh, J. P.; Meyskens, F. L.; Valanis, B.; Williams, J. H.; Barnhart, S.; Hammar, S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 1996, 334, 1150-1155. (Pubitemid 26137973)
102. Albanes, D.; Heinonen, O. P.; Taylor, PR.; Virtamo, J.; Edwards, B. K.; Rautalahti, M.; Hartman, A. M.; Palmgren, J.; Freedman, L. S.; Haapakoski, J.; Barrett, M. J.; Pietinen, P.; Malila, N.; Tala, E.; Liippo, K.; Salomaa, E. R.; Tangrea, J. A.; Teppo, L.; Askin, F. B.; Taskinen, E.; Erozan, Y.; Greenwald, P.; Huttunen, J. K. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst., 1996, 88, 1560-1570. (Pubitemid 26374509)
103. Hennekens, C. H.; Bunng, J. E.; Manson, J. E.; Stampfer, M.; Rosner, B.; Cook, N. R.; Belanger, C.; LaMotte, F.; Gaziano, J. M.; Ridker, P. M.; Willett, W.; Peto, R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med., 1996, 334, 1145-1149. (Pubitemid 26137972)
104. Greenberg, E. R.; Baron, J. A.; Stukel, T. A.; Stevens, M. M.; Mandel, J. S.; Spencer, S. K.; Elias, P. M.; Lowe, N.; Nierenberg, D. W.; Bayrd, G. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N. Engl. J. Med., 1990, 323, 789-795. (Pubitemid 20303876)
105. Greenberg, E. R.; Baron, J. A.; Tosteson, T. D.; Freeman, D. H Jr.; Beck, G. J.; Bond, J. H.; Colacchio, T. A.; Coller, J. A.; Frankl, H. D.; Haile, R. W.; Mandel, J. S.; Nierenberg, D. W.; Rothstein, R.; Snover, D. C.; Stevens, M. M.; Summers, R. W.; van Stolk, R. U. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. The Polyp Prevention Study Group. N. Engl. J. Med., 1994, 331, 141-147. (Pubitemid 24209563)
106. MacLennan, R.; Macrae, F.; Bain, C.; Battistutta, D.; Chapuis, P.; Gratten, H.; Lambert, J.; Newland, R. C.; Ngu, M.; Russell, A.; Ward, M.; Wahlqvist, M. L. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J. Natl. Cancer Inst., 1995, 87, 1760-1766.
107. Blot, W. J.; Li, J. Y.; Taylor, PR.; Guo, W.; Dawsey, S.; Wang, G. Q.; Yang, C. S.; Zheng, S. F.; Gail, M.; Li, G. Y Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst., 1993, 85, 1483-1492. (Pubitemid 23269183)
108. Li, J. Y.; Taylor, P. R.; Li, B.; Dawsey, S.; Wang, G. Q.; Ershow, A. G.; Guo, W.; Liu, S. F.; Yang, C. S.; Shen, Q. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J. Natl. Cancer Inst., 1993, 85, 1492-1498. (Pubitemid 23269184)
109. Qiao, Y-L.; Dawsey, S. M.; Kamangar, F.; Fan, J-H.; Abnet, C. C.; Sun, X-D.; Lee Johnson, L.; Mitchell H. Gail, M. H.; Dong, Z.-W.; Yu, B.; Mark, Taylor, P. R. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J. Natl. Cancer Inst., 2009, 101, 507-518.
110. Osganian, S. K.; Stampfer, M. J.; Rimm, E.; Spiegelman, D.; Manson, J. E.; Willett, W. C. Dietary carotenoids and risk of coronary artery disease in women. Am. J. Clin. Nutr., 2003, 77, 1390-1399. (Pubitemid 39655271)
111. Klipstein-Grobusch, K.; Geleijnse, J. M.; den Breeijen, J. H.; Boeing, H.; Hofman, A.; Grobbee, D. E.; Witteman, J. C. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr., 1999, 69, 261-266. (Pubitemid 29065549)
112. Tavani, A.; Negri, E.; D'Avanzo, B.; La Vecchia, C. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women. Eur. J. Epidemiol., 1997, 13, 631-637. (Pubitemid 27375066)
113. Hennekens, C. H.; Buring, J. E.; Manson, J. E.; Stampfer, M.; Rosner, B.; Cook, N. R.; Belanger, C.; LaMotte, F.; Gaziano, J. M.; Ridker, P. M.; Willett, W.; Peto, R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med., 1996, 334, 1145-1149. (Pubitemid 26137972)
114. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA, 1996, 275, 699-703.
115. Rapola, J. M.; Virtamo, J.; Ripatti, S.; Huttunen, J. K.; Albanes, D.; Taylor, P. R.; Heinonen, O. P. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 1997, 349, 1715-1720. (Pubitemid 27252669)
116. Cassileth, B. Lycopene. Oncology (Willston Park), 2010, 24, 296.
117. Khachik, F.; Carvalho, L.; Bernstein, P. S.; Muir, G. J.; Zhao, D. Y.; Katz, N. B. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med., 2002, 227, 845-851. (Pubitemid 35340337)
118. Gartner, C.; Stahl, W.; Sies, H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr., 1997, 66, 116-122. (Pubitemid 27278908)
119. Agarwal, S.; Rao, A. V. Tomato lycopene and its role in human healt and chronic diseases. CMAJ, 2000, 163, 739-744.
120. Unlu, N. Z.; Bohn, T.; Francis, D. M.; Nagaraja, H. N.; Clinton, S. K.; Schwartz, S. J. Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. B r. J. Nutr., 2007, 98, 140-146. (Pubitemid 47272157)
121. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys., 1989, 274, 532-538. (Pubitemid 19261144)
122. Heber, D.; Lu, Q-Y. Overview of mechanisms of action of lycopene. Exp. Biol. Med. (Maywood), 2002, 227, 920-923. (Pubitemid 35340348)
123. Levy, J.; Bosin, E.; Feldman, B.; Giat, Y.; Miinster, A.; Danilenko, M.; Sharoni, Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr. Cancer, 1995, 24, 257-266.
124. Sesso, H. D.; Buring, J. E.; Zhang, S. M.; Norkus, E. P.; Gaziano, J. M. Dietary and plasma lycopene and the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1074-1081. (Pubitemid 40656450)
125. Järvinen, R.; Knekt, P.; Seppänen, R.; Teppo, L. Diet and breast cancer risk in a cohort of Finnish women. Cancer Lett., 1997, 114, 251-253. (Pubitemid 27140125)
126. Zhang, S.; Tang, G.; Russell, R. M.; Mayzel, K. A.; Stampfer, M. J.; Willett, W. C.; Hunter, D. J. Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am. J. Clin. Nutr., 1997, 66, 626-632. (Pubitemid 27366788)
127. Giovannucci, E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer Inst., 1999, 91, 317-331. (Pubitemid 29102331)
128. Etminan, M.; Takkouche, B.; Caamano-Isorna, F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 340-345. (Pubitemid 38737456)
129. Kolonel, L. N.; Hankin, J. H.; Whittemore, A. S.; Wu, A. H.; Gallagher, R. P.; Wilkens, L. R.; John, E. M.; Howe, G. R.; Dreon, D. M.; West, D. W.; Paffenbarger, R. S Jr. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 795-804. (Pubitemid 30660052)
130. Kirsh, V. A.; Mayne, S. T.; Peters, U.; Chatterjee, N.; Leitzmann, M. F.; Dixon, L. B.; Urban, D. A.; Crawford, E. D.; Hayes, R. B. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., 2006, 15, 92-98.
131. Sesso, H. D.; Buring, J. E.; Norkus, E. P.; Gaziano, J. M. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am. J. Clin. Nutr., 2004, 79, 47-53. (Pubitemid 41132061)
132. Sesso, H. D.; Liu, S.; Gaziano, J. M.; Buring, J. E. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J. Nutr., 2003, 133, 2336-2341. (Pubitemid 36841562)
133. Kohlmeier, L.; Kark, J. D.; Gomez-Gracia, E.; Martin, B. C.; Steck, S. E.; Kardinaal, A. F.; Ringstad, J.; Thamm, M.; Masaev, V.; Riemersma, R.; Martin-Moreno, J. M.; Huttunen, J. K.; Kok, F. J. Lycopene and myocardial infarction risk in the EURAMIC Study. Am. J. Epidemiol., 1997, 146, 618-626. (Pubitemid 27454549)
134. Patil, B. S.; Jayaprakasha, G. K.; Chidambara Murthy, K. N. Vikram A. Bioactive compounds: historical perspectives, opportunities, and challenges. J. Agric. Food Chem., 2009, 57, 8142-8160.
135. Ross, J. A.; Kasum, C. M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 2002, 22, 19-34. (Pubitemid 35221452)
136. McKay, D. L.; Blumberg, J. B. The Role of Tea in Human Health: An Update. J. Am. Coll. Nutr., 2002, 21, 1-13. (Pubitemid 34123703)
137. USDA: "USDA Database for the flavonoid Contents of Selected Foods." Beltsville: US Department of Agricukture, 2003
138. Wang, Y.; Ho, CT. Polyphenolic chemistry of tea and coffee: a century of progress. J. Agric. Food Chem., 2009, 57, 8109-8114.
139. Wu, C. D.; Wei, G. X. Tea as a functional food for oral health. Nutrition, 2002, 18, 443-444. (Pubitemid 34414981)
140. Lin, Y. S.; Tsai, Y. J.; Tsay, J. S.; Lin, J. K. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J. Agric. Food Chem., 2003, 51, 1864-1873.
141. Hakim, I. A.; Harris, R. B.; Weisgerber, U. M. Tea intake and squamous cell carcinoma of the skin: influence of type of tea beverages. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 727-731. (Pubitemid 30482705)
142. Cabrera, C.; Artacho, R.; Giménez, R. Beneficial effects of green tea-a review. J. Am. Coll. Nutr., 2006, 25, 79-99. (Pubitemid 46939847)
143. Chow, H. H.; Cai, Y.; Alberts, D. S.; Hakim, I.; Dorr, R.; Shahi, F.; Crowell, J. A.; Yang, C. S.; Hara, Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev., 2001, 10, 53-58. (Pubitemid 32106044)
144. Kim, S.; Lee, M. J.; Hong, J.; Li, C.; Smith, T. J.; Yang, G. Y.; Seril, D. N.; Yang, C. S. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer., 2000, 37, 41-48. (Pubitemid 30650665)
145. Lambert, J. D.; Sang, S.; Yang, C. S. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharm., 2007, 4, 819-825.
146. Wang, Y.; Ho, C. T. Metabolism of flavonoids. Forum Nutr., 2009, 61, 64-74.
147. Prior, R. L.; Wu, X.; Gu, L. Flavonoid metabolism and challenges to understanding mechanisms of health effects. J. Sci. Food Agric., 2006, 86, 2487-2491. (Pubitemid 44884987)
148. Kondo, K.; Kurihara, M.; Miyata, N.; Suzuki, T.; Toyoda, M. Scavenging mechanisms of (-)-epigallocatechin gallate and (-) - epicatechin gallate on peroxyl radicals and formation of superoxide during the inhibitory action. Free Radic. Biol. Med., 1999, 27, 855-863. (Pubitemid 29454589)
149. Guo, Q.; Zhao, B.; Shen, S.; Hou, J.; Hu, J.; Xin, W. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim. Biophys. Acta, 1999, 1427, 13-23. (Pubitemid 29123856)
150. Valcic, S.; Burr, J. A.; Timmermann, B. N.; Liebler, D. C. Antioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals. Chem. Res. Toxicol., 2000, 13, 801-810.
151. Liang, C. P.; Wang, M.; Simon, J. E.; Shahidi, F.; Ho, C. T. In Antioxidant Measurement and applications; Shahidi F, Ho CT, Eds.; Oxford University Press: Oxford, UK., 2007, 207; pp. 125-139
152. Zhu, Q.; Liang, C. P.; Cheng, K. W.; Peng, X.; Lo, C. Y.; Shahidi, F.; Chen, F.; Ho, C. T.; Wang, M. Trapping effects of green and black tea extracts on peroxidation-derived carbonyl substances of seal blubber oil. J. Agric. Food Chem., 2009, 57, 1065-1069.
153. Noda, Y.; Peterson, D. G. Structure-reactivity relationships of flavan-3-ols on product generation in aqueous glucose/glycine model systems. J. Agric. Food Chem., 2007, 55, 3686-3691. (Pubitemid 46806593)
154. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation endproducts: a review. Diabetologia, 2001, 44, 129-146.
155. Sang, S.; Shao, X.; Bai, N.; Lo, C. Y.; Yang, C. S.; Ho, C. T. Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chem. Res. Toxicol, 2007, 20, 1862-1870.
156. Jakus, V.; Rietbrock, N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol. Res., 2004, 53, 131-142. (Pubitemid 38525116)
157. Lapolla, A.; Flamini, R.; Dalla, Vedova A, Senesi, A.; Reitano, R.; Fedele, D.; Basso, E.; Seraglia, R.; Traldi, P. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med., 2003, 41, 1166-1173. (Pubitemid 37265695)
158. Nagaraj, R. H.; Sarkar, P.; Mally, A.; Biemel, K. M.; Lederer, M. O.; Padayatti, PS. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch. Biochem. Biophys., 2002, 402, 110-119. (Pubitemid 34848300)
159. Lo CY, Li S, Tan D, Pan MH, Sang S, Ho CT Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions. Mol. Nutr. Food Res., 2006, 50, 1118-1128. (Pubitemid 46032200)
160. Tan, D.; Wang, Y.; Lo, C. Y.; Sang, S.; Ho, CT. Methylglyoxal: its presence in beverages and potential scavengers. Ann. N. Y. Acad. Sci., 2008, 1126, 72-75. (Pubitemid 351589289)
161. Ahn, H. Y.; Xu, Y.; Davidge, ST. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci., 2008, 82, 964-968.
162. Pan, M. H.; Lai, C. S.; Dushenkov, S.; Ho, C. T. Modulation of inflammatory genes by natural dietary bioactive compounds. J. Agric. Food Chem., 2009, 57, 4467-4477.
163. Wheeler, D. S.; Catravas, J. D.; Odoms, K.; Denenberg, A.; Malhotra, V.; Wong, H. R. Epigallocatechin-3-gallate, a green teaderived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J. Nutr., 2004, 134, 1039-1044. (Pubitemid 38619936)
164. Kundu, J. K.; Na, H. K.; Chun, K. S.; Kim, Y. K.; Lee, S. J.; Lee, S. S.; Lee, O. S.; Sim, Y. C.; Surh, Y. J. Inhibition of phorbol esterinduced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr., 2003, 133, 3805S-3810S. (Pubitemid 37392604)
165. Kundu, J. K.; Surh, Y. J. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-k B and CREB in mouse skin: role of p38 MAPK. Ann. N. Y. Acad. Sci., 2007, 1095, 504-512. (Pubitemid 47092481)
166. Zaveri, N. T. Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications Life Sci., 2006, 78, 2073-2080.
167. Schoonbroodt, S., Piette, J. Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem. Pharm., 2000, 60, 1075-1083.
168. Kojima-Yuasa, A.; Hua, J. J.; Kennedy, D. O.; Matsui-Yuasa, I. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci., 2003, 73, 1299-1313. (Pubitemid 36794594)
169. Waleh, N.; Chao, W. R.; Bensari, A.; Zaveri, N. T. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells. Anticancer Res., 2005, 25, 397-402. (Pubitemid 40470136)
170. Fernández, PL.; Pablos, F.; Martín, M. J.; González, A. G. Study of catechin and xanthine tea profiles as geographical tracers. J. Agric. Food Chem., 2002, 50, 1833-1838.
171. Feng, Q.; Kumagai, T.; Torii, Y.; Nakamura, Y.; Osawa, T.; Uchida, K. Anticarcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Radic Res., 2001, 35, 779-788. (Pubitemid 34065667)
172. Kondo, T.; Ohta, T.; Igura, K.; Hara, Y.; Kaji; K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett., 2002, 180, 139-144. (Pubitemid 34327366)
173. Chung, F. L.; Schwartz, J.; Herzog, C. R.; Yang YM. Tea and cancer prevention: studies in animals and humans. J. Nutr., 2003, 133, 3268S-3274S. (Pubitemid 37222255)
174. Lambert, J. D.; Yang, C. S. Mechanisms of cancer prevention by tea constituents. J. Nutr., 2000, 133, 3262S-3267S.
175. Mittal, A.; Pate, M. S.; Wylie, R. C.; Tollefsbol, T. O.; Katiyar, S. K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol., 2004, 24, 703-710.
176. Fujiki, H.; Suganuma, M.; Okabe, S.; Sueoka, E.; Suga, K.; Imai, K.; Nakachi, K.; Kimura, S. Mechanistic findings of green tea as cancer preventive for humans. Proc. Soc. Exp. Biol. Med., 1999, 220, 225-228.
177. Yam, T. S.; Shah, S.; Hamilton-Miller, J. M. Microbiological activity of whole and fractionated crude extracts of tea (Camellia sinensis), and of tea components. FEMS Microbiol. Lett., 1997, 152, 169-174. (Pubitemid 27293283)
178. Khan, N.; Mukhtar, H. Tea polyphenols for health promotion. Life Sci., 2007, 81, 519-533. (Pubitemid 47212236)
179. Yang, M.; Wang, C.; Chen, H. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J. Nutr. Biochem., 2001, 12, 14-20. (Pubitemid 32120192)
180. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors, 2000, 13, 49-54. (Pubitemid 32107344)
181. Zhong, L.; Goldberg, M. S.; Gao, Y. T.; Hanley, J. A.; Parent, M. E.; Jin, F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology, 2001, 12, 695-700. (Pubitemid 33138163)
182. Wu, A. H.; Yu, M. C.; Tseng, C. C.; Hankin, J.; Pike, M. C. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer, 2003, 106, 574-599.
183. Inoue, M.; Tajima, K.; Mizutani, M.; Iwata, H.; Iwase, T.; Miura, S.; Hirose, K.; Hamajima, N.; Tominaga, S. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett., 2001, 167, 175-182. (Pubitemid 32706681)
184. Jian, L.; Xie, L. P.; Lee, A. H.; Binns, C. W. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer., 2004, 108, 130-135. (Pubitemid 37444455)
185. Kurahashi, N.; Sasazuki, S.; Iwasaki, M.; Inoue, M.; Tsugane, S. JPHC Study Group. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am. J. Epidemiol., 2008, 167, 71-77.
186. Hoshiyama, Y.; Kawaguchi, T.; Miura, Y.; Mizoue, T.; Tokui, N.; Yatsuya, H.; Sakata, K.; Kondo, T.; Kikuchi, S.; Toyoshima, H.; Hayakawa, N.; Tamakoshi, A.; Ohno, Y.; Yoshimura, T. Japan Collaborative Cohort Study Group A prospective study of stomach cancer death in relation to green tea consumption in. Jpn. B r. J. Cancer, 2002, 87(3), 309-313.
187. Kono, S. Green tea and gastric cancer in Japan. N. Engl. J. Med., 2001, 344(24), 1867-1868. (Pubitemid 32538705)
188. Borrelli, F.; Capasso, R.; Russo, A.; Ernst, E. Systematic review: green tea and gastrointestinal cancer risk. Aliment. Pharmacol. Ther., 2004, 19, 457-510.
189. Hoshiyama, Y.; Kawaguchi, T.; Miura, Y.; Mizoue, T.; Tokui, N.; Yatsuya, H.; Sakata, K.; Kondo, T.; Kikuchi, S.; Toyoshima, H.; Hayakawa, N.; Tamakoshi, A.; Ohno, Y.; Yoshimura, T. Japan Collaborative Cohort Study Group. A nested case-control study of stomach cancer in relation to green tea consumption in Japan. Br. J. Cancer, 2004, 90, 135-138. (Pubitemid 38174952)
190. Yuan, J. M.; Gao, Y. T.; Yang, C. S.; Yu, M. C. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int. J. Cancer, 2006, 120, 1344-1350.
191. Koizumi, Y.; Tsubono, Y.; Nakaya, N.; Nishino, Y.; Shibuya, D.; Matsuoka, H.; Tsuji, I. No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 472-473. (Pubitemid 36578489)
192. Gomikawa, S.; Ishikawa, Y.; Hayase, W.; Haratake, Y.; Hirano, N.; Matuura, H.; Mizowaki, A.; Murakami, A.; Yamamoto, M. Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe. J. Med. Sci., 2008, 54, E62-72.
193. Geleijnse, J. M.; Launer, L. J.; Hofman, A.; Pols, H. A.; Witteman, J. C. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch. Intern. Med., 1999, 159, 2170-2174. (Pubitemid 29483156)
194. Sesso, H. D.; Gaziano, J. M.; Buring, J. E.; Hennekens, CH. Coffee and tea intake and the risk of myocardial infarction. Am. J. Epidemiol., 1999, 149, 162-167. (Pubitemid 29039519)
195. Duffy, S. J.; Keaney, JF Jr.; Holbrook, M.; Gokce, N.; Swerdloff, P. L.; Frei, B.; Vita, J. A. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation, 2001, 104, 151-156. (Pubitemid 32655830)
196. Hertog, M. G.; Sweetnam, P. M.; Fehily, A. M.; Elwood, P. C.; Kromhout, D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nut r., 1997, 65, 1489-1494. (Pubitemid 27187762)
197. Yang, C. S.; Lambert, J. D.; Sang, S. Antioxidative and anticarcinogenic activities of tea polyphenols. Arch. Toxicol., 2008, 83, 11-21.
198. Ju, J.; Lu, G.; Lambert, J. D.; Yang, C. S. Inhibition of carcinogenesis by tea constituents. Semin. Cancer Biol., 2007, 17, 395-402. (Pubitemid 47369175)
199. Gibson, R. A.; Lines, D. R.; Neumann, R. A. Gamma linolenic acid (GLA) content of encapsulated evening primrose products. Lipids, 1992, 27, 82-84.
200. Birch, A. E.; Fenner, G. P.; Watkins, R.; Boyd, L. C. Antioxidant properties of evening primrose seed extracts. J. Agric. Food Chem., 2001, 49, 4502-4507. (Pubitemid 32896459)
201. Arimura, T.; Kojima-Yuasa, A.; Suzuki, M.; Kennedy, D. O.; Matsui-Yuasa, I. Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett., 2003, 201, 9-16. (Pubitemid 37297992)
202. Hardy, M. L. Herbs of special interest to women. J. Am. Pharm. Assoc., 2000, 40, 234-242.
203. Mera, S. L. Diet and disease. B r. J. Biomed. Sci., 1994, 51, 189-206. (Pubitemid 24301646)
204. Dirks, J.; Aswegen, C. H.; Du Plessis, D. J.; Snyman, J. R. Effect of evening primrose oil on monocyte chemotactic protein-1 and tumour necrosis factor-alpha levels during delayed hypersensitivity immune responses. Med. Sci. Res., 1998, 26, 561-567.
205. Munoz, S. E.; Lopez, C. B.; Valentich, M. A.; Eynard, A. R. Differential modulation by dietary n-6 or n-9 unsaturated fatty acids on the development of two murine mammary gland tumors having different metastatic capabilities. Cancer Lett., 1998, 126, 149-55. (Pubitemid 28181598)
206. Lu, F.; Foo, Y.; Phenolic antioxidant components of evening primrose in Nutrition, Lipids, Health and Disease, Ong, A. S. H., Niki, E.; and Parker, L., Eds.; AOCS Press: Champaign, IL, 1995
207. Frankel, E. N.; Huang, S.-W.; Aeschbach, R.; Prior, E. Antioxidant activity of a rosemary extract and its constituents, carnosic acid, carnosol, and rosmarinic acid, in bulk oil and oil-in-water emulsion. J. Agric. Food Chem., 1996, 44, 131-135 (Pubitemid 126458550)
208. Wettasinghe, M.; Shahidi, F. Evening primrose meal: a source of natural antioxidants and scavenger of hydrogen peroxide and oxygen-derived free radicals. J. Agric. Food Chem., 1999, 47, 1801-1812. (Pubitemid 29438720)
209. Wettasinghe, M.; Shahidi, F. Iron (II) chelation activity of extracts of borage and evening primrose meals. Food Res. Int., 2002, 35, 65-71. (Pubitemid 34775863)
210. Wettasinghe, M.; Shahidi, F.; Amarowicz, R. Identification and quantification of low molecular weight phenolic antioxidants in seeds of evening primrose (Oenothera biennis L.). J. Agric. Food Chem., 2002, 50, 1267-1271 (Pubitemid 34194092)
211. Wettasinghe, M.; Shahidi, F. scavenging of reactive-oxygen species and DPPH free radicals by extracts of borage and evening primrose meals. Food Chem., 2000, 70, 17-26. (Pubitemid 30227577)
212. Halliwel, B.; Gutteridge, J. M. C. Free radicals in biology and medicine. Oxford, UK: Oxford University Press 1985.
213. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G, Penninger JM, Peleato ML, Kroemer G, Susin SA. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem., 2001, 276, 16391-16398.
214. Arimura, T.; Kojima-Yuasa, A.; Suzuki, M.; Kennedy, D. O.; Matsui-Yuasa I. Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett., 2003, 201, 9-16. (Pubitemid 37297992)
215. Herrera, B.; Alvarez, A. M.; Sánchez, A.; Fernández, M.; Roncero, C.; Benito, M.; Fabregat, I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J., 2001, 15, 741-751. (Pubitemid 32245992)
216. Fernandez, D. C.; Andres, D.; Cascales, M.; Attenuating effect of heat shock against TGF-p1-induced apoptosis in cultured rat hepatocytes. Free Radic. Biol. Med., 2002, 33, 835-846. (Pubitemid 35232318)
217. Arimura, T.; Kojima-Yuasa, A.; Watanabe, S.; Suzuki, M.; Kennedy, D. O.; Matsui-Yuasa, I. Role of intracellular reactive oxygen species and mitochondrial dysfunction in evening primrose extract-induced apoptosis in Ehrlich ascites tumor cells. Chem. Biol. Interact., 2003, 145, 337-347. (Pubitemid 36549117)
218. Borutaite, V.; Brown, G. C. Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett., 2001, 500(3), 114-118. (Pubitemid 32607543)
219. Riley, D. J.; Lee, E. Y.; Lee, W. H. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell Biol., 1994;10, 1-29. (Pubitemid 24372814)
220. Sambucetti, L. C.; Fischer, D. D.; Zabludoff, S.; Kwon, P. O.; Chamberlin, H.; Trogani, N.; Xu, H.; Cohen, D. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J. Biol. Chem., 1999, 274, 34940-34947. (Pubitemid 129509542)
221. Kawada, M.; Kuwahara, A.; Nishikiori, T.; Mizuno, S.; Uehara, Y. NA22598, a novel antitumor compound, reduces cyclin D1 levels, arrests cell cycle at G1 phase, and inhibits anchorage-independent growth of human tumor cells. Exp. Cell Res., 1999, 249, 240-247. (Pubitemid 29397931)
222. Arimura, T.; Kojima-Yuasa, A.; Kennedy, D. O.; Matsui-Yuasa, I. Reactive oxygen species-independent G1 arrest induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett., 2004, 207, 19-25. (Pubitemid 38429883)
223. Shan, B. E.; Zeki, K.; Sugiura, T.; Yoshida, Y.; Yamashita, U. Chinese medicinal herb, Acanthopanax gracilistylus, extract induces cell cycle arrest of human tumor cells in vitro. Jpn. J. Cancer Res., 2000, 91, 383-389. (Pubitemid 30312689)
224. Serrano, A.; Palacios, C.; Roy, G.; Cespón, C.; Villar, M. L.; Nocito, M.; González-Porqué, P. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch. Biochem. Biophys., 1998, 350, 49-54. (Pubitemid 28371167)
225. Ohno, Y.; Fukuda, K.; Takemura, G.; Toyota, M.; Watanabe, M.; Yasuda, N.; Xinbin, Q.; Maruyama, R.; Akao, S.; Gotou, K.; Fujiwara, T.; Fujiwara H. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs, 1999, 10, 845-851. (Pubitemid 30011832)
226. Pellegrina, CD.; Padovani, G.; Mainente, F.; Zoccatelli, G.; Bissoli, G.; Mosconi, S.; Veneri, G.; Peruffo, A.; Andrighetto, G.; Rizzi, C.; Chignola, R. Anti-tumour potential of a gallic acidcontaining phenolic fraction from Oenothera biennis. Cancer Lett., 2005, 226, 17-25. (Pubitemid 40943426)
227. Tapiero, H.; Tew, K. D.; Ba, G. N.; Mathé, G. Polyphenols: do they play a role in the prevention of human pathologies? Biomed. Pharmacother, 2002, 56, 200-207. (Pubitemid 34628383)
228. Kiss, A. K.; Derwihska, M.; Dawidowska, A.; Naruszewicz M. Novel biological properties of Oenothera paradoxa defatted seed extracts: effects on metallopeptidase activity. J. Agric. Food Chem., 2008, 56, 7845-7852.
229. Corti, R.; Burnett Jr, J. C.; Rouleau, J. L.; Ruschitzka, F.; Lüscher, T. F. Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation, 2001, 104, 1856-1862. (Pubitemid 32963354)
230. Imig, J. D. ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement. Hypertension, 2004, 43, 533-535. (Pubitemid 38282423)
231. Shimizu, T.; Tani, K.; Hase, K.; Ogawa, H.; Huang, L.; Shinomiya, F.; Sone, S. CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum., 2002, 46, 2330-2338.
232. Saiki, I.; Fujii, H.; Yoneda, J.; Abe, F.; Nakajima, M.; Tsuruo, T.; Azuma, I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer, 1993, 54, 137-143. (Pubitemid 23137011)
233. Aggarwal, B. B.; and Shishodia, S. Resveratrol in health and disease. Taylor & Francis, CRC Press, 2006.
234. Constant, J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis., 1997, 8, 645-649. (Pubitemid 28029590)
235. Fremont, L. Biological effects of resveratrol. Life Sci., 2000, 66, 663-673.
236. Belguendouz, L.; Fremont, L.; Gozzelino, M. T. Interaction of trans-resveratrol with plasma lipoproteins. Biochem. Pharmacol, 1998, 55, 811-816.
237. Frankel, E. N.; Kanner, J.; German, J. B.; Parks, E.; Kinsella, J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet, 1993, 341, 454-457. (Pubitemid 23054518)
238. Kerry, N. L.; Abbey, M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis, 1997, 135, 93-102. (Pubitemid 27469700)
239. Wang, Z.; Huang, Y.; Zou, J.; Cao, K.; Xu, Y.; Wu, J. M. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int. J. Mol. Med., 2002, 9, 77-79.
240. Rotondo, S.; Rajtar, G.; Manarini, S.; Celardo, A.; Rotillo, D.; de Gaetano, G.; Evangelista, V.; Cerletti, C. Effect of transresveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol, 1998, 123, 1691-1699. (Pubitemid 28182053)
241. Hung, L. M.; Chen, J. K.; Huang, S. S.; Lee, R. S.; Su, M. J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res., 2000, 47, 549-555.
242. McGowan, F. X. Jr.; Davis, P. J.; del Nido, PJ, Sobek, M.; Allen, J. W. Downing SE. Endothelium-dependent regulation of coronary tone in the neonatal pig. Anesth. Analg., 1994, 79, 1094-1101. (Pubitemid 24363612)
243. Kubes, P.; Suzuki, M.; Granger, D. N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A., 1991, 88, 4651-4655. (Pubitemid 21914599)
244. Groves, PH.; Lewis, M. J.; Cheadle, H. A.; Penny, W. J. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation, 1993, 87, 590-597. (Pubitemid 23040929)
245. Hung, L. M.; Su, M. J.; Chen, J. K. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NOindependent mechanisms. Free Radic. Biol. Med., 2004, 36, 774-781.
246. Das, S.; Alagappan, V. K.; Bagchi, D.; Sharma, H. S.; Maulik, N.; Das, D. K. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vasc. Pharmacol, 2005, 42, 281-289. (Pubitemid 40726331)
247. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275, 218-220. (Pubitemid 127696281)
248. Kundu, J. K.; Surh, Y. J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett., 2008, 269, 243-261.
249. Mnjoyan, Z. H.; Fujise, K. Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53-p21 (WAF1/CIP1) pathway. Biochem. Biophys. Res. Commun., 2003, 311, 546-552. (Pubitemid 37340114)
250. Narayanan, B. A.; Narayanan, N. K.; Re, G. G.; Nixon, D. W. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int. J. Cancer, 2003, 104, 204-212 (Pubitemid 36249796)
251. Fontecave, M.; Lepoivre, M.; Elleingand, E.; Gerez, C.; Guittet, O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett., 1998, 421, 277-279. (Pubitemid 28045770)
252. Sun, N. J.; Woo, S. H.; Cassady, J. M.; Snapka, R. M. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod., 1998, 61, 362-366. (Pubitemid 28160726)
253. Hsieh, T. C.; Juan, G.; Darzynkiewicz, Z.; Wu, J. M. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res., 1999, 59, 2596-2601. (Pubitemid 29269105)
254. Tai, S. H.; Lin-Shiau, S. Y.; Lin, J. K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol, 1999, 126, 673-680.
255. Banerjee, S.; Bueso-Ramos, C.; Aggarwal, B. B. Suppression of 7, 12-dimethylbenz (a) anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res., 2002, 62, 4945-4954. (Pubitemid 34984418)
256. Lv, L.; Shao, X.; Wang, L.; Huang, D.; Ho, CT.; Sang S. Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal. J. Agric. Food Chem., 2010, 58, 2239-2245.
257. Shih, Y. L.; Liu, H. C.; Chen, C. S.; Hsu, C. H.; Pan, M. H.; Chang, H. W.; Chang, C. H.; Chen, F. C.; Ho. C. T.; Yang, Y. Y.; Ho, Y. S. Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors. J. Agric. Food Chem., 2010, 58, 235-241.
258. Pan, M. H.; Lin, C. L.; Tsai, J. H.; Ho, C. T.; Chen, W. J. 3, 5, 3', 4', 5'-pentamethoxystilbene (MR-5), a synthetically methoxylated analogue of resveratrol, inhibits growth and induces g1 cell cycle arrest of human breast carcinoma MCF-7 cells. J. Agric. Food Chem., 2010, 58, 226-234.
259. Lai, C. S.; Lee, J. H.; Ho, C. T.; Liu, C. B.; Wang, J. M.; Wang, Y. J.; Pan, M. H. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways. J. Agric. Food Chem., 2009, 57, 10990-10998.
260. Lo, Y. H.; Pan, M. H.; Li, S.; Yen, J. H.; Kou, M. C.; Ho, C. T.; Wu, M. J. Nobiletin metabolite, 3', 4'-dihydroxy-5, 6, 7, 8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells. Biochim. Biophys. Acta, 2010, 1801, 114-126.
261. Lian, T. W.; Wang, L.; Lo, Y. H.; Huang, I. J.; Wu, M. J. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochim. Biophys. Acta, 2008, 1781, 601-609.
262. Kuo, Y. C.; Lai, C. S.; Wang, J. M.; Badmaev, V.; Nagabhushanam, K.; Ho, C. T.; Pan, M. H. Differential inhibitory effects of inotilone on inflammatory mediators, inducible nitric oxide synthase and cyclooxygenase-2, in LPS-stimulated murine macrophage. Mol. Nutr. Food Res., 2009, 53, 1386-1395.
263. Pan, M. H.; Chang, Y. H.; Tsai, M. L.; Lai, C. S.; Ho, S. Y.; Badmaev, V.; Ho, C. T. Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. J. Agric. Food Chem., 2008, 56, 7502-7509.
264. Weng, C. J.; Yang, Y. T.; Ho, C. T.; Yen, G. C. Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells. J. Agric. Food Chem., 2009, 57, 5235-5243.
265. Shankar, S.; Siddiqui, I.; Srivastava, R. K. Molecular mechanisms of resveratrol (3, 4, 5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgeninsensitive prostate cancer cells. Mol. Cell Biochem., 2007, 304, 273-285. (Pubitemid 47456876)
266. Pan, M. H.; Gao, J. H.; Lai, C. S.; Wang, Y. J.; Chen, W. M.; Lo, C. Y.; Wang, M.; Dushenkov, S.; Ho, C. T. Antitumor activity of 3, 5, 4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice. Mol. Carcinog., 2008, 47, 184-196. (Pubitemid 351398062)
267. Lea, M. A.; Ibeh, C.; Han, L.; Desbordes, C. Inhibition of growth and induction of differentiation markers by polyphenolic molecules and - in colon cancer cells. Anticancer Res., 2010, 30, 311-318.
268. Sharif, T.; Auger, C.; Alhosin, M.; Ebel, C.; Achour, M.; Etienne-Selloum, N.; Fuhrmann, G.; Bronner, C.; Schini-Kerth, V. B. Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redox-sensitive upregulation of p73 and down-regulation of UHRF1. Eur. J. Cancer, 2010, 46, 983-994.
269. Sharif, T.; Auger, C.; Bronner, C.; Alhosin, M.; Klein, T.; Etienne-Selloum, N.; Schini-Kerth, V. B.; Fuhrmann, G. Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell. Invest. New Drugs., 2009 [Epub ahead of print].
270. Kramer, M. P.; Wesierska-Gadek, J. Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose. Ann. N. Y. Acad. Sci., 2009, 1171, 257-263.
271. Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Roberti, M.; Pizzirani, D.; Meli, M.; Dusonchet, L.; Gebbia, N.; Abbadessa, V.; Crosta, L.; Barucchello, R.; Grisolia, G.; Invidiata, F.; Simoni, D. Pterostilbene and 30- hydroxypterostilbene are effective apoptosisinducing agents in MDR and BCR-ABL-expressing leukemia cells. Int. J. Biochem. Cell Biol., 2005, 37, 1709-1726. (Pubitemid 40719649)
272. Simoni, D.; Roberti, M.; Invidiata, F. P.; Aiello, E.; Aiello, S.; Marchetti, P.; Baruchello, R.; Eleopra, M.; Di Cristina, A.; Grimaudo, S.; Gebbia, N.; Crosta, L.; Dieli, F.; Tolomeo, M. Stilbenebased anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Bioorg. Med. Chem. Lett., 2006, 16, 3245-3248.
273. Aggarwal, B. B.; Bhardwaj, A.; Aggarwal, R. S.; Seeram, N. P.; Shishodia, S.; Takada, Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res., 2004, 24, 2783-2840. (Pubitemid 39409568)
274. Riboli, E.; Norat, T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr., 2003, 78, 559S-569S. (Pubitemid 40012550)
275. Pavia, M.; Pileggi, C.; Nobile, C. G.; Angelillo, I. F. Association between fruit and vegetable consumption and oral cancer: a metaanalysis of observational studies. Am. J. Clin. Nutr., 2006, 83, 1126-1134. (Pubitemid 44713114)
276. Conway, D. I. Each portion of fruit or vegetable consumed halves the risk of oral cancer. Evid. Based Dent., 2007, 8, 19-20.